Dress syndrome and fulminant hepatic failure induced by lamotrigine

被引:42
|
作者
Fabian Amante, Marcelo [1 ]
Veronica Filippini, Analia [1 ]
Cejas, Nora [2 ]
Lendoire, Javier [2 ]
Imventarza, Oscar [2 ]
Parisi, Coloma [1 ]
机构
[1] Dr Cosme Argerich Gen Hosp, Dept Pathol, Buenos Aires, DF, Argentina
[2] Dr Cosme Argerich Gen Hosp, Liver Transplantat Unit, Buenos Aires, DF, Argentina
关键词
Antiepileptic drug; liver transplantation; histopathology; hypersensitivity syndrome; hepatotoxicity; HYPERSENSITIVITY SYNDROME;
D O I
10.1016/S1665-2681(19)31817-4
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Lamotrigine is a non-aromatic antiepileptic drug. Drug rash with eo,eosinophilia and systemic symptoms (DRESS) syndrome is a severe idiosyncratic reaction to drugs, especially and-epileptic drugs. Associated clinical features include cutaneous eruption, fever, multiple peripheral lymphadenopathies, and potentially life-threatening damage of one or more organs. We re.. port a case of DRESS syndrome induced by lamotrigine presenting with a hypersensitivity syndrome and fulminant hepatic failure requiring liver transplant. A 21-year old female patient presented an episode of seizure with loss of conscience. CT and EEG studies performed were normal. Treatment with lamotrigine was prescribed. In the course of 30 days, the patient developed skin lesions, pruritus, cholestatic hepatitis, and systemic symptoms -fever, lymphadenopathies, extensive exfoliative erythematous maculopapular rash, and jaundice. Serologic anti laboratory tests showed no other causes responsible for the clinical spectrum. Hematologic tests revealed peripheral eosinophilia. Fulminant hepatic failure was diagnosed and an orthotopic liver transplant was performed. Histologic sections of the ex.. planted liver demonstrated submassive hepatic necrosis, with the remnant portal spaces and lobules showing a mixed inflammatory infiltrate with lymphocytes and eosinophils. Lamotringine treatment has been associated with multiorgan failure, DRESS syndrome, acute hepatic failure, anti disseminated intravascular coagulation. In conclusion, we suggest that these potentially fatal side effects should be considered in any patient with clinical deterioration following administration of this drug.
引用
收藏
页码:75 / 77
页数:3
相关论文
共 50 条
  • [1] FULMINANT HEPATIC-FAILURE INDUCED BY LAMOTRIGINE
    MAKIN, AJ
    FITT, S
    WILLIAMS, R
    DUNCAN, JS
    BRITISH MEDICAL JOURNAL, 1995, 311 (7000): : 292 - 292
  • [2] Lamotrigine and the risk of fulminant hepatic failure
    Shawcross, Debbie
    Auzinger, Georg
    LANCET, 2008, 371 (9613): : 649 - 650
  • [3] Fulminant hepatic failure secondary to lamotrigine
    Shah, S
    Wang, WZ
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2005, 100 (09): : S126 - S127
  • [4] Lamotrigine and the risk of fulminant hepatic failure
    Iniesta, Ivan
    LANCET, 2007, 370 (9605): : 2101 - 2101
  • [5] Lamotrigine induced DRESS syndrome
    Naveen, Kikkeri Narayanasetty
    Ravindra, Mysore Satyanarayana
    Pai, Varadraj V.
    Rai, Vijetha
    Athanikar, Sharatchandra B.
    Girish, Meravanige
    INDIAN JOURNAL OF PHARMACOLOGY, 2012, 44 (06) : 798 - 800
  • [6] Fatal eosinophilic myocarditis and submassive hepatic necrosis in lamotrigine induced DRESS syndrome
    Doan, Khanh Duy
    Akinsanya, Adeyinka
    Kuhar, Matthew
    Mesa, Hector
    ALLERGY ASTHMA AND CLINICAL IMMUNOLOGY, 2023, 19 (01):
  • [7] Fatal eosinophilic myocarditis and submassive hepatic necrosis in lamotrigine induced DRESS syndrome
    Khanh Duy Doan
    Adeyinka Akinsanya
    Matthew Kuhar
    Hector Mesa
    Allergy, Asthma & Clinical Immunology, 19
  • [8] Lamotrigine hypersensitivity syndrome with fatal fulminant hepatic necrosis
    不详
    CLINICAL TOXICOLOGY, 2005, 43 (06): : 635 - 636
  • [9] Lamotrigine induced dress syndrome in bipolar disorder
    Oriolo, Giovanni
    Brugues, A.
    Pintor, Luis
    Goikolea, Jose M.
    ACTAS ESPANOLAS DE PSIQUIATRIA, 2017, 45 (03): : 133 - 136
  • [10] Sulfasalazine Induced Dress Syndrome with Fulminant Hepatitis
    Slim, R.
    Fathallah, N.
    Ouni, B.
    Larif, S.
    Hmouda, H.
    Ben Salem, C.
    DRUG SAFETY, 2018, 41 (11) : 1191 - 1192